Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Next Vial vs Thriving Again

Next Vial
Graded #345

Lower grade

vs+0.20000000000000284
Thriving Again
Graded #341

Higher grade

The verdict

Thriving Again takes it — 59.5/100 to 59.3/100, but only just.

Thriving Again grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Thriving Again is a US telehealth platform positioned around premium men's health and optimization, with hormone/TRT, peptides, and a GLP-1 weight loss line. Next Vial is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueThriving Again +5
40
45
Dose & formulationNext Vial +12
52
40
Clinical oversightNext Vial +6
82
76
Labs & monitoringThriving Again +36
52
88
FulfillmentNext Vial +24
86
62
Contract termsEven
55
55
Next Vial · left barThriving Again · right bar

The numbers

MetricNext VialThriving Again
WeighScore59.3/10059.5/100
GradeCC
Scorecard rank#345#341
Semaglutide$250/mo (compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
Coverage49 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Next Vial

Graded #345 · C

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Where it loses points

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states
Thriving Again

Graded #341 · C

Strengths

  • Compounded GLP-1 with at-home labs and ongoing provider messaging
  • Advertises nationwide coverage with 500+ licensed providers
  • Pre-filled syringe delivery simplifies dosing
  • Combines weight loss with hormone and peptide optimization

Where it loses points

  • No specific GLP-1 dose or monthly pricing published online
  • Weight loss is one vertical alongside men's hormone and TRT care
  • Compounded products are not FDA-approved or evaluated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard